评估1型糖尿病儿童及其父母在糖尿病夏令营环境中参加多日人工胰腺临床试验的体验
研究在7天夏令营期间通过半结构化访谈、糖尿病治疗满意度问卷(DTSQ)和人工胰腺接受度问卷,评估30名5-9岁1型糖尿病儿童及其父母参加人工胰腺临床试验的体验。父母主要关注新设备的机制、风险与获益,对血糖控制质量有顾虑,但总体满意并持积极态度;多数父母认为人工胰腺易于使用、打算长期使用并认为其有助于改善血糖控制。作者结论为参与者态度积极,需进一步研究在人工胰腺开发早期探索参与者感知,以个体化治疗并贴合其需求与价值观。
要点
- 30名5-9岁1型糖尿病儿童及其父母完成7天夏令营人工胰腺临床试验体验评估。
- 父母主要关注新设备的机制、风险与获益,对血糖控制质量存在顾虑。
- 多数父母认为人工胰腺易于使用(70.5%)、打算长期使用(94.0%)并认为其有助于改善血糖控制(67.0%)。
核心结论
- 参与者对人工胰腺表现出积极态度。
- 作者认为需进一步研究在人工胰腺开发早期探索参与者感知,以尽可能个体化新治疗并使其贴合参与者的需求与价值观。
研究设计与样本
- 在7天夏令营期间开展的人工胰腺临床试验结束后进行半结构化访谈,访谈包含基于技术接受模型的14个问题。
- 参与者同时完成糖尿病治疗满意度问卷(DTSQ,父母版)和人工胰腺接受度问卷。
- 30名5-9岁儿童及其父母完成了研究。
主要发现
- 访谈内容分析显示,父母关注理解新设备的机制、风险与获益,而儿童关注新系统的新颖性。
- 父母采用新系统的主要顾虑似乎与血糖控制质量有关。
- DTSQ子量表平均分显示父母总体满意(44.24 ± 5.99,范围32-53),并对新系统提供的糖尿病控制持信任看法(7.8 ± 2.2,范围3-12)。
- 人工胰腺接受度问卷显示,大多数父母认为人工胰腺易于使用(70.5%)、打算长期使用(94.0%),并认为其有助于改善血糖控制(67.0%)。
局限性
- 作者指出需进一步研究在人工胰腺开发早期探索参与者感知,以尽可能个体化新治疗并使其贴合参与者的需求与价值观。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the experiences of children with type 1 diabetes and their parents taking part in an artificial pancreas (AP) clinical trial during a 7-day summer camp. RESEARCH DESIGN AND METHODS: A semistructured interview, composed of 14 questions based on the Technology Acceptance Model, was conducted at the end of the clinical trial. Participants also completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ, parent version) and the AP Acceptance Questionnaire. RESULTS: Thirty children, aged 5-9 years, and their parents completed the study. A content analysis of the interviews showed that parents were focused on understanding the mechanisms, risks, and benefits of the new device, whereas the children were focused on the novelty of the new system. The parents' main concerns about adopting the new system seemed related to the quality of glucose control. The mean scores of DTSQ subscales indicated general parents' satisfaction (44.24 ± 5.99, range 32-53) and trustful views of diabetes control provided by the new system (7.8 ± 2.2, range 3-12). The AP Acceptance Questionnaire revealed that most parents considered the AP easy to use (70.5%), intended to use it long term (94.0%), and felt that it was apt to improve glucose control (67.0%). CONCLUSIONS: Participants manifested a positive attitude toward the AP. Further studies are required to explore participants' perceptions early in the AP development to individualize the new treatment as much as possible, and to tailor it to respond to their needs and values.
引用
- Troncone A, Bonfanti R, Iafusco D, et al. Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting. Diabetes Care. 2016. PMID: 27852685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。